← Back to Search

Personalized Physical Rehabilitation for Kidney Transplant Recipients

N/A
Waitlist Available
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
at least 2 moths post-transplant
must have adequate cognitive ability to complete questionnaires, give consent for the study and follow the physical instructions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month
Awards & highlights

Study Summary

This trial will compare a new 12-month exercise program to standard care for people who have had a kidney transplant. The goal is to see if the exercise program helps people return to work, and also improves things like heart health, fitness, and quality of life.

Who is the study for?
This trial is for kidney transplant recipients who are at least two months post-transplant, can understand and answer questions, and follow exercise instructions. It's not for those with heart or lung disease that makes exercise risky, recent weight loss surgery patients, non-walkers, or people with major bone/joint issues.Check my eligibility
What is being tested?
The study tests a personalized 12-month exercise program against standard care in kidney transplant patients. It looks at how the program affects job return rates, heart health markers, physical ability, body makeup changes, life quality improvements and if it helps keep the new kidney working well.See study design
What are the potential side effects?
Since this is an exercise-based intervention rather than a drug trial, side effects may include typical risks associated with physical activity such as muscle soreness or injury. The exact side effects will depend on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had my transplant surgery more than 2 months ago.
Select...
I can understand and follow study instructions and fill out questionnaires.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Return to work or find work rate
Secondary outcome measures
Body Composition
Functional capacity
Inflammatory marker
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise RehabiliationExperimental Treatment1 Intervention
12 month personalized exercise rehabilitation in addition to standard clinical care
Group II: ControlActive Control1 Intervention
Standard clinical care only
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise Rehabilitation
2015
N/A
~180

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
602 Previous Clinical Trials
1,558,358 Total Patients Enrolled

Media Library

Exercise Rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT02409901 — N/A
Kidney Transplant Research Study Groups: Exercise Rehabiliation, Control
Kidney Transplant Clinical Trial 2023: Exercise Rehabilitation Highlights & Side Effects. Trial Name: NCT02409901 — N/A
Exercise Rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT02409901 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include participants over the age of 45?

"In order to be eligible for this trial, participants must not exceed 65 years old and are required to have reached the age of majority."

Answered by AI

Do I meet the qualifications for participation in this medical experiment?

"The patient population of this research consists of 153 individuals aged 18-65 who have recently undergone a kidney transplant. In addition, they must possess the mental aptitude necessary to follow study instructions and complete questionnaires, in adition to providing their consent for the trial."

Answered by AI

Are there currently openings for new participants in this experiment?

"Clinicaltrials.gov reports that this trial, first initiated on October 1st 2014, is not currently accepting patients for participation. However, there are 85 other medical studies which have open enrollment as of June 8th 2021."

Answered by AI
~0 spots leftby Apr 2024